Markets

Catheter maker Infraredx withdraws $56 million IPO

Infraredx, which markets a FDA-cleared optical catheter that identifies lipid core coronary plaques, withdrew its plans for an initial public offering on Friday citing poor market conditions.

It had planned to raise $56 million at a market cap of $214 million during late January, but postponed its offering.

The Burlington, MA-based company was founded in 1998 and booked $5 million in sales for the 12 months ended September 30, 2014. It had planned to list on the NASDAQ under the symbol REDX. RBC Capital Markets, Canaccord Genuity and BMO Capital Markets were set to be the joint bookrunners on the deal.

The article Catheter maker Infraredx withdraws $56 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AVGR

Other Topics

IPOs

Latest Markets Videos

    Renaissance Capital

    Renaissance Capital is the global leader in providing pre-IPO institutional research and management of IPO-focused investment products.

    Learn More